Hongbo Wang

10PUBLICATIONS
15CO-AUTHORS
Molecular targetsBiologically active moleculesPharmacogenomicsTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2025
Preclinical Evaluation of the Oral Toxicity, Genotoxicity, and Safety Pharmacology of LPM4870108, a Novel Potent Tropomyosin Receptor Kinase Inhibitor.

Xiaochen Zhang, Baiyang Yuan, Chunmei Li

|Jul 16, 2025
Development of a Highly Potent Neurokinin‑3 Receptor Inhibitor: Design, Synthesis, and Evaluation.

Shengmin Ji, Hui Wang, Hengwei Xu

|Jul 15, 2025
Optimization of Thienopyrimidine Derivatives as Potent and Selective PI3Kδ Inhibitors for Cancer Immunotherapy.

Songwen Lin, Nan Xiang, Wenqian Liu

|Jun 04, 2025
Design, Synthesis, and Evaluation of Pyrazolopyridine Derivatives as Novel Calreticulin (CALR) Ligands That Inhibit Triple-Negative Breast Cancer (TNBC) via Inducing Calcium Overloading.

Jiaguo Lu, Anqi Yin, Shenpeng Tan

|Jan 11, 2025
Ultrasonic Microfluidic Method Used for siHSP47 Loaded in Human Embryonic Kidney Cell-Derived Exosomes for Inhibiting TGF-β1 Induced Fibroblast Differentiation and Migration.

Ranran Yuan, Zhen Mu, Houqian Zhang

|Aug 26, 2024
Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors.

Qikun Yin, Yuemiao Hu, Zhiwen Dong

Pageof 2

Frequent Collaborators

2 joint publications

Qikun Yin

1 joint publications

Jiaqi Liu

1 joint publications

Xianzun Tao

1 joint publications

Yi Zhu